1932 ⎘
Rearing or breeding animals, not otherwise provided for; New breeds of animals; New breeds of vertebrates Chimeric animals, e.g. comprising exogenous cells
HUMAN SEBACEOUS GLAND CARCINOMA CELL LINE AND US THEREOF
#2Immune Cell-Engrafted Non-Human Animals and Non-Human Animal Models
#3SKIN TISSUE
#4COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#5METHOD FOR PRODUCING A SPONTANEOUS METASTASIS MODEL
#6NON-HUMAN ANIMALS COMPRISING A MODIFIED TRANSFERRIN RECEPTOR LOCUS
#7ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#8HUMANIZED IMMUNODEFICIENT MOUSE MODELS
#9Genetically Modified Mice and Engraftment
#10METHODS AND MODELS FOR ASSESSING EFFICACY OF IMMUNOTHERAPIES
#11THYMOCYTE HUMANIZED ANIMALS, METHODS OF MAKING AND METHODS OF USE THEREOF
#12AAVR KNOCKOUT MOUSE IN COMBINATION WITH HUMAN LIVER CHIMERISM AND METHODS OF USE AND PRODUCTION OF THE SAME
#13MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#14Compositions for Treating Pathological Calcification Conditions, and Methods Using Same
#15METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#16HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME
#17VECTORS, GENETICALLY MODIFIED CELLS, AND GENETICALLY MODIFIED NON-HUMAN ANIMALS COMPRISING THE SAME
#18METHOD OF MAKING IN VIVO HUMAN SMALL INTESTINE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#19IMMUNODEFICIENT FCGR1 KNOCKOUT MOUSE MODELS
#20METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS
#21PROCESS OF TRANSFECTING PRIMORDIAL GERM CELLS IN AN AVIAN
#22HUMANIZED MOUSE MODEL OF FIBROSIS
#23BRAIN-METASTATIC LUNG CANCER CELL LINE AND USE OF NOGGIN AS MARKER FOR BRAIN METASTASIS OF LUNG CANCER
#24Humanized M-CSF Mice
#25Genetically Modified Non-Human Animals And Methods Of Use Thereof
#26USE OF ALVEOLAR OR AIRWAY ORGANOIDS FOR THE TREATMENT OF LUNG DISEASES AND DISORDERS
#27Genetically Modified Hepatocyte Populations
#28COMPOSITION FOR TREATING OR PREVENTING IMMUNOLOGICAL ABNORMAL INFLAMMATORY DISEASES
#29METHOD FOR PREPARING PLURIPOTENT STEM CELL-DERIVED HEMATOPOIETIC STEM CELL AND METHOD FOR CONSTRUCTING HUMANIZED MOUSE MODEL BY USING HEMATOPOIETIC STEM CELL THUS PREPARED
#30CELLS HAVING ABILITY TO INDUCE SKIN APPENDAGES, AND PRODUCTION METHOD THEREOF
#31GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE
#32Formation of Three-Dimensional Organ from Pluripotent Stem Cells
#33NME INHIBITORS AND METHODS OF USING NME INHIBITORS
#34COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS OF THE CENTRAL NERVOUS SYSTEM
#35NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES
#36HUMAN FIBROLAMELLAR HEPATOCELLULAR CARCINOMAS (hFL-HCCS)
#37METHOD OF MAKING IN VIVO HUMAN SMALL INTESTINE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#38T CELL REGULATION
#39COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE
#40STEM-CELL BASED BIOMARKER DISCOVERY
#41METHOD FOR CULTURING 3-DIMENSIONAL LUNG CANCER ORGANOID AND METHOD FOR PREPARING PATIENT-DERIVED XENOGRAFT ANIMAL MODEL USING SAME
#42MAINTENANCE OF PROGRAMMED CHRONIC LIVER INJURY OF FAH GENE-DEFICIENT ANIMALS AND APPLICATION THEREOF IN PREPARATION OF HETEROLOGOUS LIVER MODELS
#43TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#44GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO
#45Animal Models and Therapeutic Molecules
#46SIMULATION METHOD FOR CHRONIC ATROPHIC GASTRITIS (CAG) LESION AND IDENTIFICATION METHOD FOR MOUSE MODELING
#47INFECTIOUS DISEASE MOUSE MODELS
#48GENERATION OF SURROGATE SIRES AND DAMS BY ABLATION OF ENDOGENOUS GERMLINE
#49Materials for Tumor Inoculation in Murine Mouse Models and Uses Thereof
#50APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS
#51ETV2 AND USES THEREOF
#52HUMAN LIVER CHIMERIC NON-HUMAN ANIMAL WITH DEFICIENT P450 OXIDOREDUCTASE AND METHODS OF USING SAME
#53METHOD FOR PRODUCING AVATAR MOUSE AS ATOPIC DERMATITIS ANIMAL MODEL AND USE THEREOF
#54BLADDER ORGANOID AND METHOD FOR PRODUCING SAME
#55GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF
#56HUMANIZED CHIMERAS FOR THE PROSPECTIVE ASSESSMENT OF CELL ADDITION AND REPLACEMENT THERAPIES
#57METHOD FOR CONSTRUCTING MODEL OF VITILIGO AND THE USE OF THE MODEL
#58Animal Models and Therapeutic Molecules
#59Animal Models and Therapeutic Molecules
#60IMMUNE CELLS DERIVED FROM INDUCED PLURIPOTENT STEM CELL
#61Process for using CRISPR to transfect primordial germ cells in avians
#62NON-HUMAN MAMMAL MODEL OF HUMAN DEGENERATIVE DISORDER, USES THEREOF, AND METHOD OF TREATING HUMAN DEGENERATIVE DISORDER
#63ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY
#64OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS
#65METHODS FOR CANCER TREATMENT
#66PRIMATIZED RODENT
#67METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN
#68COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT
#69MODIFIED MICE THAT PRODUCE HEAVY CHAIN ONLY ANTIBODIES
#70GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPa/CD47
#71TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#72GENETICALLY MODIFIED NON-HUMAN ANIMALS WITH HUMAN OR CHIMERIC THPO
#73HUMANIZED MOUSE MODEL WITH HUMAN IMMUNE SYSTEM
#74NON-HUMAN ANIMALS COMPRISING A HUMANIZED TRKB LOCUS
#75METHODS OF TREATING MYOINTIMAL PROLIFERATION
#76Genetically Modified Non-Human Animals and Methods of Use Thereof
#77ORGAN REGENERATION METHOD UTILIZING BLASTOCYST COMPLEMENTATION
#78METHOD OF MAKING HUMAN MOUSE XENOGRAFTS
#79METHODS FOR ANALYZING TUMOR INNATE IMMUNE INTERACTIONS USING THE ZEBRAFISH XENOGRAFT MODEL AS A LIVING BIOMARKER
#80PHARMACEUTICAL FORMULATIONS CONTAINING CD80 EXTRACELLULAR DOMAIN-FC FUSION PROTEINS
#81MOUSE MODEL FOR ASSESSING TOXICITIES ASSOCIATED WITH IMMUNOTHERAPIES
#82NME INHIBITORS AND METHODS OF USING NME INHIBITORS
#83Compositions and methods for producing genetically modified animals
#84METHOD FOR ENHANCING TUMOR GROWTH
#85ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#86METHODS FOR PRODUCING ANTIGEN-BINDING PROTEINS AGAINST FOREIGN ANTIGENS
#87Method for integrating biological tissues with a vascular system
#88Compositions for treating pathological calcification conditions, and methods using same
#89NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#90NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#91USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG
#92NON-HUMAN ANIMAL MODELS OF SÉZARY SYNDROME
#93MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES
#94GENETICALLY MODIFIED PIGS FOR XENOTRANSPLANTATION OF VASCULARIZED XENOGRAFTS AND DERIVATIVES THEREOF
#95IMMUNOLOGICALLY COMPATIBLE CELLS, TISSUES, ORGANS, AND METHODS FOR TRANSPLANTATION FOR SILENCING, HUMANIZATION, AND PERSONALIZATION WITH MINIMIZED COLLATERAL GENOMIC DISRUPTIONS
#96METHODS FOR GENERATING FUNCTIONAL HEMATOPOIETIC STEM CELLS
#97DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#98ANIMAL MODEL FOR AMPLIFYING HUMAN OR ANIMAL CIRCULATING TUMOR CELLS
#99COMPOSITION FOR RECONSTITUTING HUMAN SKIN TISSUE HAVING HAIR FOLLICLES, HUMAN SKIN TISSUE MODEL ANIMAL, AND PRODUCTION METHOD THEREOF
#100Genetically Modified Mice and Engraftment
#101SMALL ANIMAL MODELS FOR IN VIVO TESTING OF POLYOMAVIRUS THERAPEUTICS
#102ISOLATED NASOPHARYNGEAL CARCINOMA CELLS AND DERIVATIVES PREPARED THEREOF
#103RNA-BASED METHODS TO LAUNCH HEPATITIS B VIRUS INFECTION
#104Genetically modified non-human animals and methods of use thereof
#105Non-human animal having human IL-34 and use Thereof
#106USE OF AN EGG GRAFTED WITH TUMOR CELLS IN ORDER TO STUDY THE ANTI-CANCER EFFECTIVENESS OF IMMUNE THERAPIES IN THE ABSENCE OF IMMUNE EFFECTOR CELLS OTHER THAN THOSE IN THE GRAFTED EGG
#107GENERATION OF A POPULATION OF HINDBRAIN CELLS AND HINDBRAIN-LIKE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#108METHODS AND MATERIALS FOR IMPROVING TRANSPLANT OUTCOMES
#109COMPOSITIONS AND METHODS FOR TREATING A TUMOR SUPPRESSOR DEFICIENT CANCER
#110TELOMERASE REVERSE TRANSCRIPTASE-BASED THERAPIES
#111T CELL REGULATION
#112GENERATION OF HUMAN ENDODERMAL ORGANS IN PIG MODEL USING LINEAGE RESTRICTED ENDODERMAL PRECURSORS
#113Peptidic TGF-beta antagonists
#114GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE
#115Esophageal tissue and/or organoid compositions and methods of making same
#116HUMANIZED HEART MUSCLE
#117NON-HUMAN ANIMALS HAVING A HUMANIZED A PROLIFERATION-INDUCING LIGAND GENE
#118Humanized skeletal muscle
#119Humanized Mouse Model
#120SINGLE LUNG CELL-DERIVED ORGANOIDS
#121Single kidney cell-derived organoids
#122Genetic modification of rats
#123Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same
#124Humanized M-CSF mice
#125Process of transfecting primordial germ cells in an avian
#126Production of fertile XY female animals by silencing of genes on the Y chromosome
#127IMMUNODEFICIENT NON-HUMAN ANIMAL
#128Liver lesion-mouse model
#129PRODUCTION AND USE OF RED BLOOD CELLS
#130Method for preparing a large animal model with peritoneal carcinomatosis
#131INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#132Use of alveolar or airway organoids for the treatment of lung diseases and disorders
#133Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#134Development of superior chimerism by hiPSC engineering and embryo aggregation
#135Method of treating psoriatic arthritis with increased interval dosing of anti-IL12/23 antibody
#136Animal Models and Therapeutic Molecules
#137Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#138Animal Models and Therapeutic Molecules
#139Animal Models and Therapeutic Molecules
#140Animal Models and Therapeutic Molecules
#141METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
#142Method for producing chimeric animal
#143NON-HUMAN ANIMAL AND METHOD FOR PRODUCING SAME
#144APPLICATION OF PLURIPOTENT STEM CELLS HAVING MODIFIED DIFFERENTIAL POTENTIAL TO PRODUCING ANIMALS
#145HLA G-MODIFIED CELLS AND METHODS
#146Rapid tumorigenicity screening system
#147TARGETING GLIOBLASTOMA STEM CELLS THROUGH THE TLX-TET3 AXIS
#148Methods of treating myointimal proliferation
#149Methods of Generating Mature Human Muscle Fibers
#150METHODS AND COMPOSITIONS FOR ALLEVIATING CYTOKINE RELEASE SYNDROME
#151Construct having structure and cell mass linked together
#152Methods for treating pseudoxanthoma elasticum (PXE)
#153Chimeric mouse comprising stably transplanted bat cells
#154Genetically modified non-human animals and methods of use thereof
#155Avian induced pluripotent stem cells and their use
#156METHODS OF REPROGRAMMING ANIMAL SOMATIC CELLS
#157Methods for cancer treatment
#158Compositions for treating pathological calcification conditions, and methods using same
#159Finding and treatment of inflammation after birth in chimeric animal
#160PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM
#161Genetically modified non-human animals and methods of use thereof
#162Non-invasive in vivo imaging and methods for treating type I diabetes
#163Genetically modified non-human animals expressing human EPO
#164CD34+,CD45- PLACENTAL STEM CELL-ENRICHED CELL POPULATIONS
#165METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
#166HLA G-modified cells and methods
#167Compositions and methods for treating diseases and disorders of the central nervous system
#168Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#169Rat model of down syndrome and method for producing same
#170ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#171Anti-NRP1 antibody screening method
#172Method for Determining the Effectiveness of Treatment for the Prevention of Heartworm Disease
#173ORGAN REGENERATION METHOD UTILIZING BLASTOCYST COMPLEMENTATION
#174Methods of engineering human induced pluripotent stem cells to produce liver tissue
#175Genetically modified non-human animal with human or chimeric TIM-3
#176TUMOR CELL XENOGRAFT MODEL IN ZEBRAFISH, AND METHODS OF CONSTRUCTING AND USING THE SAME
#177Urokinase-type plasminogen activator transgenic mouse
#178REGENERATION METHOD USING SOMATIC CELL NUCLEAR TRANSFER (SCNT) CELL AND BLASTOCYST COMPLEMENTATION
#179HUMANIZED MOUSE MODEL WITH IMPROVED HUMAN INNATE IMMUNE CELL DEVELOPMENT
#180Immunodeficient non-human animal
#181Genetic modification of rats
#182Three Dimensional Bioprinted Tumor Models for Drug Testing
#183Genetically modified mice and engraftment
#184METHOD FOR PRODUCING FOUNDER ANIMAL FOR REPRODUCING ANIMAL HAVING LETHAL PHENOTYPE CAUSED BY GENE MODIFICATION
#185GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION
#186Identification of factor that promotes human HSC self-renewal
#187Process for using crispr to transfect primordial germ cells in avians
#188Engineering of Humanized Kidney by Genetic Complementation
#189Induced dendritic cells and uses thereof
#190Genetically modified major histocompatibility complex mice
#191Genetically modified major histocompatibility complex mice
#192Compositions for treating pathological calcification conditions, and methods using same
#193Immune cells derived from induced pluripotent stem cell
#194METHOD OF CONSTRUCTING HUMANIZED MURINE MODEL OF CHRONIC VIRAL HEPATITIS USING STEM CELL
#195Compositions and methods for identification, assessment, prevention, and treatment of AML using USP10 biomarkers and modulators
#196METHODS AND COMPOSITIONS RELATING TO IMPROVED HUMAN RED BLOOD CELL SURVIVAL IN GENETICALLY MODIFIED IMMUNODEFICIENT NON-HUMAN ANIMALS
#197Methods for generating functional hematopoietic stem cells
#198Human liver chimeric mouse with deficient P450 oxidoreductase
#199Human fibrolamellar hepatocellular carcinomas (hFL-HCCs)
#200Genetically modified rat comprising a humanized locus
#201STEM CELLS FOR MODELING TYPE 2 DIABETES
#202ORGAN REGENERATION METHOD UTILIZING iPS CELL AND BLASTOCYST COMPLEMENTATION
#203Peptidic TGF-beta antagonists
#204Genetically modified non-human animals and methods of use thereof
#205Non-invasive in vivo imaging and methods for treating diabetes
#206Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#207Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse
#208INDUCIBLE DISEASE MODELS METHODS OF MAKING THEM AND USE IN TISSUE COMPLEMENTATION
#209Targeting glioblastoma stem cells through the TLX-TET3 axis
#210EFFICIENT, SCALABLE PATIENT-DERIVED XENOGRAFT SYSTEM BASED ON A CHICK CHORIOALLANTOIC MEMBRANE (CAM) IN VIVO MODEL
#211Transgenic pig which simultaneously expresses HO-1 gene and TNFR1-Fc gene, and comprises knocked-out GGTA1 gene, and use thereof
#212Compositions and methods for enhanced genome editing
#213HUMANIZED MOUSE MODEL OF MYASTHENIA GRAVIS AND MSC THERAPY
#214Animal study model for cancer
#215Method for producing chimeric animal
#216METHOD FOR MANUFACTURING TISSUE/ORGAN BY USING BLOOD CELLS
#217Mode of inducing renal transplant rejection on animals and its manufacturing approach
#218USE OF MAPK INHIBITORS TO REDUCE LOSS OF HEMATOPOIETIC STEM CELLS DURING EX VIVO CULTURE AND/OR GENETIC MANIPULATION
#219High-throughput mouse model for optimizing antibody affinities
#220Genetically modified non-human animals and methods of use thereof
#221TRANSGENIC NON-HUMAN ANIMAL EXPRESSING HUMAN SPECIFIC MOLECULE AND HUMAN FCy RECEPTOR FAMILY
#222Method for measuring tumor burden in patient derived xenograft (PDX) mice
#223Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
#224GENERATION OF HUMAN MACROPHAGES IN IMMUNODEFICIENT NON-HUMAN HOSTS
#225Method for generating a humanized transgenic mouse comprising a human APRIL gene
#226Mouse lymphoma cell line and animal model of human high grade B-cell lymphoma
#227Delivery, use and therapeutic applications of the CRISPR-cas systems and compositions for modeling mutations in leukocytes
#228Methods of increasing T cell immune response in the treatment of cancer
#229PROCESS FOR INDUCING RESISTANCE TO DIPHTHERIA TOXIN IN HUMAN CELLS, PRODUCTS AND USES THEREOF
#230Methods and compositions for producing pancreatic beta cells
#231Isolated Populations of Female Germline Stem Cells and Cell Preparations and Compositions Thereof
#232Induced extended pluripotent stem cells, method of making and using
#233Non-HLA matched humanized NSG mouse model with patient-derived xenograft
#234Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#235Production and use of red blood cells
#236Humanized skeletal muscle
#237Humanized heart muscle
#238Method for producing blood chimeric animal
#239CELL STRUCTURE, NON-HUMAN MODEL ANIMAL, METHOD FOR PRODUCING NON-HUMAN MODEL ANIMAL, AND METHOD FOR EVALUATING TEST SUBSTANCE
#240Transgenic Immunodeficient Mouse Expressing Human SIRP-alpha
#241HUMANIZED MICE AND USES THEREOF
#242Non-obese diabetes mice and its applications
#243CELL CULTURE SYSTEMS FOR PRODUCING IL-33 INDUCED T9 CELLS AND METHODS OF USING THE CELLS
#244Method for producing non-human large mammal or fish each capable of producing gamete originated from different individual
#245Genetically modified major histocompatibility complex mice
#246Disease model pig exhibiting stable phenotype, and production method thereof
#247Combination immune therapy and cytokine control therapy for cancer treatment
#248METHODS AND COMPOSITIONS RELATING TO AN EMBRYONIC STEM CELL-BASED TUMOR MODEL
#249Progressively tumorigenic cell lines
#250Compositions for treating pathological calcification conditions, and methods using same
#251Compositions for treating pathological calcification conditions, and methods using same
#252Compositions for treating pathological calcification conditions, methods, and host cells using the same
#253Method for reducing the inflammatory activity of a stem cell transplant and use thereof
#254Genetically modified pig cells with an inactivated Etv2 gene
#255Method of treating psoriasis with increased interval dosing of anti-IL12/23 antibody
#256Genetically Modified Non-Human Animals And Methods Of Use Thereof
#257In vivo methods for identifying cancer-associated immunotherapy targets
#258Compositions for treating pathological calcification conditions, and methods using same
#259Compositions for treating pathological calcification conditions, and methods using same
#260METHODS FOR BREAKING IMMUNOLOGICAL TOLERANCE USING MULTIPLE GUIDE RNAS
#261Method for reestablishment of pluripotent stem cells
#262Method for producing antigen-specific B cells and their use for the production of hybridoma cells and monoclonal antibodies
#263Methods and compositions for generating a mouse
#264HLA G-modified cells and methods
#265Method of making in vivo human small intestine organoids from pluripotent stem cells
#266ORGAN REGENERATION METHOD UTILIZING BLASTOCYST COMPLEMENTATION
#267Humanized M-CSF mice
#268Methods for establishing animal model of hepatocellular carcinoma bone metastasis
#269Three-Dimensional Hydrogels that Support Growth of Physiologically Relevant Tissue and Methods of Use Thereof
#270Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain
#271METHOD FOR PRODUCING ANIMAL MODEL OF OSTEOBLASTIC BONE METASTASIS
#272Telomerase reverse transcriptase-based therapies
#273TRANSGENIC CHICKENS WITH AN INACTIVATED ENDOGENOUS GENE LOCUS
#274Animal models, cell lines and methods for screening hepatitis C virus vaccines
#275Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo
#276Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#277Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
#278Isolation and use of solid tumor stem cells
#279Genetically modified mice and engraftment
#280METHOD FOR PRODUCING TISSUE AND ORGAN
#281ANIMAL MODEL FOR STUDYING NEUROBLASTOMAS
#282ENGINEERING OF HUMANIZED CAR T-CELL AND PLATELETS BY GENETIC COMPLEMENTATION
#283METHODS OF REPROGRAMMING ANIMAL SOMATIC CELLS
#284Genetically modified major histocompatibility complex mice
#285HUMANIZED MOUSE MODELS AND USES THEREOF
#286METHODS INVOLVING MACROPHAGE TUMOR CELL FUSION HYBRIDS
#287NORMALIZATION OF THE ENTEROHEPATIC CIRCULATION IN ANIMALS WITH A CHIMERIC HUMANIZED LIVER
#288METHOD OF GENERATING STERILE TERMINAL SIRES IN LIVESTOCK AND ANIMALS PRODUCED THEREBY
#289GERMLINE TRANSMISSION OF CHICKEN PRIMORDIAL GERM CELLS (PGCS)
#290Production of fertile XY female animals by silencing of genes on the Y chromosome
#291ANIMAL MODELS AND THERAPEUTIC MOLECULES
#292Methods and compositions for mitochondrial replacement therapy
#293Rodent model of prostate cancer
#294Mouse model of hyperuricemia
#295Genetic modification of rats
#296Human SIRPα transgenic mice and their methods of use
#297Non-invasive in vivo imaging and methods for treating type I diabetes
#298High-throughput mouse model for optimizing antibody affinities
#299Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#300COMPOSITIONS AND METHODS FOR PRODUCING GENETICALLY MODIFIED ANIMALS